Journal
JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 21, Pages -Publisher
MDPI
DOI: 10.3390/jcm10214878
Keywords
uterine adenomyosis; infertility; heavy menstrual bleeding; dysmenorrhea; medical treatment; GnRH antagonist; conservative surgery
Categories
Funding
- Fonds National de la Recherche Scientifique de Belgique [FC39041, 5/4/150/5]
- PregLem via the Fondation Saint-Luc
Ask authors/readers for more resources
Uterine adenomyosis is a common estrogen-dependent disease affecting reproductive-age women, with no current cure available. Conservative surgery may be an option for patients wishing to preserve fertility, but carries risks and requires highly experienced surgeons. New, more effective options are needed for managing adenomyosis and improving fertility outcomes, with promising results seen in preliminary studies with gonadotropin-releasing hormone antagonists.
Uterine adenomyosis is a commonly encountered estrogen-dependent disease in reproductive-age women, causing heavy menstrual bleeding, intense pelvic pain, and infertility. Although adenomyosis was previously considered a disease of multiparous women, it is becoming increasingly evident that it also affects younger nulliparous women and may compromise their fertility potential. It is clear that hysterectomy, the standard approach to definitively manage the disease, is not an option for patients wishing to preserve their fertility, so there is an urgent need to develop novel conservative strategies. We searched the current literature for available methods for conservative management of adenomyosis, including both pharmacological and surgical approaches. There is no existing drug that can cure adenomyosis at present, but some off-label treatment options may be used to tackle disease symptoms and improve fertility outcomes. Adenomyosis in patients wishing to conceive can be 'treated' by conservative surgery, though these procedures require highly experienced surgeons and pose a considerable risk of uterine rupture during subsequent pregnancies. While currently available options for conservative management of adenomyosis do have some capacity for alleviating symptoms and enhancing patient fertility perspectives, more effective new options are needed, with gonadotropin-releasing hormone antagonists showing encouraging results in preliminary studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available